Aveanna Healthcare (NASDAQ:AVAH) Given New $6.75 Price Target at UBS Group

Key Points

• UBS Group raised Aveanna Healthcare's price target from $5.00 to $6.75, while maintaining a "sell" rating, indicating a potential downside of 4.92% from the current price.
• Multiple analysts have varying ratings for Aveanna, with Jefferies more optimistic after upgrading to a "buy" rating, while Truist Financial lowered their target price to $5.00.
• Aveanna Healthcare's share price increased to $7.10, reflecting recent market activity, while institutional investors control approximately 87.96% of the company's stock.

Aveanna Healthcare (NASDAQ:AVAH - Free Report) had its price target increased by UBS Group from $5.00 to $6.75 in a report released on Tuesday,Benzinga reports. They currently have a sell rating on the stock.

AVAH has been the topic of several other reports. Wall Street Zen raised Aveanna Healthcare from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 9th. Jefferies Financial Group raised Aveanna Healthcare from a "hold" rating to a "buy" rating and reduced their price objective for the stock from $6.25 to $6.00 in a research note on Monday, July 21st. Barclays started coverage on Aveanna Healthcare in a research note on Wednesday, July 2nd. They set an "equal weight" rating and a $5.50 price objective on the stock. Raymond James Financial upgraded Aveanna Healthcare from a "market perform" rating to an "outperform" rating and set a $9.00 target price for the company in a research report on Monday, August 11th. Finally, Truist Financial dropped their target price on Aveanna Healthcare from $6.00 to $5.00 and set a "hold" rating for the company in a research report on Wednesday, July 16th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, two have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $6.45.

Aveanna Healthcare Stock Down 1.7%

NASDAQ AVAH traded down $0.12 during trading hours on Tuesday, hitting $7.08. 999,487 shares of the company were exchanged, compared to its average volume of 1,464,981. The stock has a 50-day moving average price of $4.77 and a 200 day moving average price of $4.87. Aveanna Healthcare has a 52 week low of $3.67 and a 52 week high of $7.61. The stock has a market cap of $1.48 billion, a PE ratio of 88.50 and a beta of 1.95.

Insider Buying and Selling at Aveanna Healthcare

In related news, major shareholder J.H. Whitney Equity Partners V sold 1,560,700 shares of the business's stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $5.36, for a total value of $8,365,352.00. Following the completion of the sale, the insider owned 29,640,756 shares in the company, valued at approximately $158,874,452.16. The trade was a 5.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder Paul R. Vigano sold 1,560,700 shares of the business's stock in a transaction that occurred on Monday, May 19th. The shares were sold at an average price of $5.36, for a total value of $8,365,352.00. Following the completion of the sale, the insider owned 29,640,756 shares of the company's stock, valued at $158,874,452.16. The trade was a 5.00% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 6,977,245 shares of company stock valued at $37,037,197. 7.80% of the stock is owned by company insiders.

Institutional Trading of Aveanna Healthcare

Large investors have recently modified their holdings of the company. Banque Transatlantique SA purchased a new stake in shares of Aveanna Healthcare in the first quarter valued at approximately $25,000. BNP Paribas Financial Markets purchased a new stake in shares of Aveanna Healthcare in the fourth quarter valued at approximately $35,000. Tower Research Capital LLC TRC lifted its holdings in Aveanna Healthcare by 662.2% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company's stock worth $36,000 after buying an additional 6,854 shares during the period. Quantbot Technologies LP purchased a new stake in Aveanna Healthcare during the second quarter worth $43,000. Finally, Sagespring Wealth Partners LLC purchased a new stake in Aveanna Healthcare during the fourth quarter worth $57,000. Hedge funds and other institutional investors own 87.96% of the company's stock.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.